Allergy Therapeutics (AGY)


Latest News

Allergy Therapeutics to Present at Jefferies 2017

Director/PDMR Shareholding

Director/PDMR Shareholding

Publication of Annual Report and notice of AGM

Miscellaneous medium priority announcements

All News

RSS feeds

  • Editorial news feed for LSE:AGY Editorial
  • Regulatory news feed for LSE:AGY Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account